FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be used for cancer treatment. For this purpose efficient quantity of pharmaceutical composition, which contains nanoparticles, containing rapamycin and carrier protein is introduced to patient, quantity of rapamycin in composition constitutes from approximately 54 mg to approximately 540 mg. Group of inventions also relate to single dosage form, which contains said composition and pharmaceutically acceptable carrier, and to for cancer treatment.
EFFECT: application of claimed composition makes it possible to suppress, stabilise and/or delay cancer development and additionally provides methods of combined therapy for cancer treatment.
81 cl, 1 tbl, 6 dwg, 15 ex
